Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA Aptamer Raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing Receptors for Advanced Glycation End Product-Induced Oxidative Stress and Inflammation in the Testes of Diabetic Mice.
Mori Y, Terasaki M, Osaka N, Fujikawa T, Yashima H, Saito T, Kataoka Y, Ohara M, Higashimoto Y, Matsui T, Yamagishi SI. Mori Y, et al. Among authors: yamagishi si. Int J Mol Sci. 2024 May 29;25(11):5947. doi: 10.3390/ijms25115947. Int J Mol Sci. 2024. PMID: 38892134 Free PMC article.
A Clinical Case of Probable Sitosterolemia.
Terasaki M, Izumi M, Yamagishi SI. Terasaki M, et al. Among authors: yamagishi si. Int J Mol Sci. 2024 Jan 26;25(3):1535. doi: 10.3390/ijms25031535. Int J Mol Sci. 2024. PMID: 38338819 Free PMC article.
Subcutaneous Infusion of DNA-Aptamer Raised against Advanced Glycation End Products Prevents Loss of Skeletal Muscle Mass and Strength in Accelerated-Aging Mice.
Mori Y, Ohara M, Terasaki M, Osaka N, Yashima H, Saito T, Otoyama-Kataoka Y, Omachi T, Higashimoto Y, Matsui T, Fukui T, Yamagishi SI. Mori Y, et al. Among authors: yamagishi si. Biomedicines. 2023 Nov 22;11(12):3112. doi: 10.3390/biomedicines11123112. Biomedicines. 2023. PMID: 38137333 Free PMC article.
Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study.
Omachi T, Ohara M, Fujikawa T, Kohata Y, Sugita H, Irie S, Terasaki M, Mori Y, Fukui T, Yamagishi SI. Omachi T, et al. Among authors: yamagishi si. Diabetes Ther. 2024 Jan;15(1):111-126. doi: 10.1007/s13300-023-01493-3. Epub 2023 Oct 25. Diabetes Ther. 2024. PMID: 37880502 Free PMC article.
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.
Hirano T, Hayashi T, Sugita H, Tamasawa A, Goto S, Tomoyasu M, Yamamoto T, Ohara M, Terasaki M, Kushima H, Ito Y, Yamagishi SI, Mori Y. Hirano T, et al. Among authors: yamagishi si. J Diabetes Investig. 2023 Dec;14(12):1401-1411. doi: 10.1111/jdi.14076. Epub 2023 Aug 30. J Diabetes Investig. 2023. PMID: 37647503 Free PMC article. Clinical Trial.
227 results